News Snapshot:
China said giving coronavirus vaccines still in clinical trials to hundreds of thousands of people is justified given the risk of COVID-19 returning through its borders and the lack of any significant side-effects so far from the shots. The country authorized the emergency use of three vaccines developed by local firms China National Biotec Group Co. and Sinovac Biotech Ltd. in July to frontline workers, including medical staff treating virus patients, and to border officials. But that has since been widened to include employees of state-owned companies, and the government is also considering offering experimental jabs to students heading overseas...
